<- Go Home
Astralis Ltd.
Astralis Ltd. operates as a biotechnology company. The company engages in the developing of treatments for immune system disorders and skin diseases. Its products and development programs are used for various medical needs in the areas, such as dermatology and rheumatology. Astralis Ltd. was formerly known as Astralis Pharmaceuticals Ltd and changed its name to Astralis Ltd. in December 2001. The company was founded in 1999 and is based in Fairfield, New Jersey.
Market Cap
$320.1K
Volume
19.4K
Cash and Equivalents
$217.00
EBITDA
-$216.7K
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
N/A
Profit Margin
N/A
52 Week High
$0.01
52 Week Low
$0.00
Dividend
N/A
Price / Book Value
-0.59
Price / Earnings
19.23
Price / Tangible Book Value
-0.59
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
-$222.0K
Return on Equity
3.44%
Return on Assets
-134.88
Cash and Short Term Investments
$217.00
Debt
$247.5K
Equity
-$542.2K
Revenue
N/A
Unlevered FCF
-$319.1K
Sector
Biotechnology
Category
N/A